Safer blood clotting agents for open wounds


New toxicity results show that foams would be safer than the currently used clays as materials to stem blood flow in open wounds.

Blood loss is one of the leading causes of death in both military and civilian casualties. Currently, aluminosilicate layered clays, such as kaolin clay, are used as haemostatic agents (agents that encourage the blood to clot) in dressings to prevent fatalities. These clays have varying degrees of cytotoxicity and can be difficult to remove from wounds, which can lead to thrombosis. Recently, one clay product has been removed from use for this reason.

Now, scientists in Singapore and the US, led by Daniele Zink from the Institute of Bioengineering and Nanotechnology in Singapore and Galen Stucky from the University of California, Santa Barbara, have found, using in vitro tests, that a silica mesocellular foam (MCF-26) is 1–2 orders of magnitude less toxic to human cells than the clays, whereas its potency in promoting blood clotting is similar.  

Applying a wound dressing

Haemostatic agents are added to wound dressings to encourage the blood to clot

‘MCF-26 would be effective and safer than currently used haemostatic agents,’ says Zink. She adds that the clay particles in their tests to compare the two materials adhered to cell surfaces and were taken up into the cells’ cytoplasm. The MCF-26 was not taken up and was easy to remove.

Santiago Gómez-Ruiz, of the Universidad Rey Juan Carlos, Spain, and an expert in biocompatible materials and cytotoxicity, says that the work shows mesocellular foams to be an interesting real alternative to current haemostatic agents. ‘The properties of MCF-26 presented here open up the opportunity to further explore its behavior in vivo,’ says Gómez-Ruiz, although he expects this to be a difficult job.

Stucky also anticipates further work on the material, including ‘total cardiovascular system studies on specific organ and circulatory residence times of the MCF-26 particles, and their biodegradation and body elimination profiles’.


Related Content

New clotting drug antidote could cut surgery risk

20 April 2011 News Archive

news image

Researchers have developed a possible alternative to protamine, the only clinical drug that can counteract anticoagulants

Digging deep for safer water

27 March 2014 Premium contentFeature

news image

Arsenic-laced water is still poisoning millions of people in Asia. Nina Notman looks to see if an end is in sight

Most Read

Better batteries with pure lithium anodes

28 July 2014 Research

news image

Protective carbon nanosphere coating overcomes lithium problems, pointing the way to improved capacity

Takeover battle pushes Allergan to cut R&D jobs

28 July 2014 Business

news image

Besieged by serially acquisitive Valeant, the Botox maker will lay off 1500 staff to propel earnings growth

Most Commented

Bubble wrap could send lab costs packing

23 July 2014 Research

news image

Potential bubbles up across wide range of uses as storage and test vessels, especially for poor countries

Relativity behind mercury's liquidity

21 June 2013 Research

news image

First evidence that relativistic effects are indeed responsible for mercury's low melting point